Emerging opportunities in the viral vector manufacturing market include personalized medicine growth, expanded clinical trials, and regional manufacturing partnerships. Advances in bioprocessing and ...

Therapeutics Co. Ltd. ( ($HK:2126) ) has issued an announcement. JW Therapeutics announced that the National Medical Products ...

OXB acquires Resilience’s site in North Carolina, an FDA-approved, commercial-scale viral vector manufacturing facility In line with OXB’s ...

Cell and gene therapy outfit Oxford Biomedica said on Tuesday that it had agreed to acquire a viral vector manufacturing site ...

FA is an inherited syndrome that impairs the body's chromosomal repair systems, causing the bone marrow to lose its ability ...

IB [email protected] ReiThera to Showcase Innovative Viral Vector Platforms at ESGCT 2025Rome, Italy – September 30 2025 – ReiThera Srl, the Italian leading Contract Development ...

First commercially available cell culture solution for HEK293 cells and perfusion -– optimized for high cell density (HCD), intensified processes and perfusion cultures Additional capabilities for ...

NEW YORK – Researchers from St. Jude Children's Research Hospital are preparing to ask the US Food and Drug Administration for permission to begin clinical trials of a gene therapy they've developed ...

Following news on July 21 that the European Commission has granted marketing authorization for AUCATZYL® (obecabtagene autoleucel – obe-cel), AGC Biologics’ Milan site achieved its 10th product ...

The illustration shows how high trafficking of blood stem cells in the circulation early post-natally allows lentiviral-vector mediated in vivo gene transfer. Credit: Ella Maru studio Researchers have ...